Discover Xsphera Biosciences: leaders and pioneers in transforming cancer research with their novel ex vivo tumor tissue platform. With a 90-95% failure rate in oncology therapeutics entering clinical trials, they're changing the game. Their innovative platform predicts patient responses with precision. In revolutionizing drug development, they're driving a shift in cancer treatment and increasing success rates